Nova Eye Medical Statistics
Nova Eye Medical (ELXMF) Stock Statistics & Valuation Metrics
Total Valuation
Nova Eye Medical has a market cap or net worth of $29.90M. The enterprise value is $31.34M.
- Market Cap
- $29.90M
- Enterprise Value
- $31.34M
Share Statistics
Nova Eye Medical has 284,921,080 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 284,921,080
- Owned by Insiders
- 0.49%
- Owned by Institutions
- ―
Financial Efficiency
Nova Eye Medical’s return on equity (ROE) is -0.30 and return on invested capital (ROIC) is -26.25%.
- Return on Equity (ROE)
- -0.30
- Return on Assets (ROA)
- -0.20
- Return on Invested Capital (ROIC)
- -26.25%
- Return on Capital Employed (ROCE)
- -0.27
- Revenue Per Employee
- 115.83K
- Profits Per Employee
- -14.40K
- Employee Count
- 301
- Asset Turnover
- 1.62
- Inventory Turnover
- 3.04
Valuation Ratios
The current PE Ratio of Nova Eye Medical is -10.53. Nova Eye Medical’s PEG ratio is -0.12.
- PE Ratio
- -10.53
- PS Ratio
- 1.31
- PB Ratio
- 3.19
- Price to FCF
- -13.58
- Price to Operating Cash Flow
- -14.60
- PEG Ratio
- -0.12
Income Statement
In the last 12 months, Nova Eye Medical had revenue of 34.87M and earned -4.33M in profits. Earnings per share was -0.02.
- Revenue
- 34.87M
- Gross Profit
- 25.01M
- Operating Income
- -4.38M
- Pretax Income
- -4.33M
- Net Income
- -4.33M
- EBITDA
- -2.21M
- Earnings Per Share (EPS)
- -0.02
Cash Flow
In the last 12 months, operating cash flow was -3.12M and capital expenditures -235,000, giving a free cash flow of -3.36M billion.
- Operating Cash Flow
- -3.12M
- Free Cash Flow
- -3.36M
- Free Cash Flow per Share
- -0.01
Dividends & Yields
Nova Eye Medical pays an annual dividend of $0.29, resulting in a dividend yield of ―
- Dividend Per Share
- $0.29
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -7.36%
- Earnings Yield
- -9.51%
Stock Price Statistics
- Beta
- 7.50
- 52-Week Price Change
- -94.40%
- 50-Day Moving Average
- 0.01
- 200-Day Moving Average
- 0.04
- Relative Strength Index (RSI)
- 6.79
- Average Volume (3m)
- ―
Important Dates
Nova Eye Medical upcoming earnings date is Mar 02, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 26, 2026
- Next Earnings Date
- Mar 02, 2027
- Ex-Dividend Date
- Jul 21, 2020
Financial Position
Nova Eye Medical as a current ratio of 1.74, with Debt / Equity ratio of 16.77%
- Current Ratio
- 1.74
- Quick Ratio
- 1.15
- Debt to Market Cap
- 0.02
- Net Debt to EBITDA
- -0.65
- Interest Coverage Ratio
- -28.41
Taxes
In the past 12 months, Nova Eye Medical has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Nova Eye Medical EV to EBITDA ratio is -21.29, with an EV/FCF ratio of -14.01.
- EV to Sales
- 1.35
- EV to EBITDA
- -21.29
- EV to Free Cash Flow
- -14.01
- EV to Operating Cash Flow
- -15.06
Balance Sheet
Nova Eye Medical has $964.00K in cash and marketable securities with $2.39M in debt, giving a net cash position of -$1.43M billion.
- Cash & Marketable Securities
- $964.00K
- Total Debt
- $2.39M
- Net Cash
- -$1.43M
- Net Cash Per Share
- -$0.01
- Tangible Book Value Per Share
- $0.02
Margins
Gross margin is 71.74%, with operating margin of -12.55%, and net profit margin of -12.43%.
- Gross Margin
- 71.74%
- Operating Margin
- -12.55%
- Pretax Margin
- -12.43%
- Net Profit Margin
- -12.43%
- EBITDA Margin
- -6.33%
- EBIT Margin
- -12.55%
Analyst Forecast
The average price target for Nova Eye Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 25.35%
- EPS Growth Forecast
- 57.74%
Scores
- Smart Score
- 6
- AI Score
- ―
